-
Archives
- October 2026
- September 2026
- August 2026
- July 2026
- June 2026
- May 2026
- April 2026
- March 2026
- February 2026
- January 2026
- December 2025
- November 2025
- October 2025
- September 2025
- August 2025
- July 2025
- June 2025
- May 2025
- April 2025
- March 2025
- February 2025
- January 2025
- December 2024
- November 2024
- October 2024
- September 2024
- August 2024
- July 2024
- June 2024
- May 2024
- April 2024
- March 2024
- February 2024
- January 2024
- December 2023
- November 2023
- October 2023
- September 2023
- August 2023
- July 2023
- June 2023
- May 2023
- April 2023
- March 2023
- February 2023
- January 2023
- December 2022
- November 2022
- October 2022
- September 2022
- August 2022
- July 2022
- June 2022
- May 2022
- April 2022
- March 2022
- February 2022
- January 2022
- September 2021
- August 2021
- July 2021
- June 2021
- May 2021
- April 2021
- February 2021
- January 2021
- December 2020
- November 2020
- October 2020
- September 2020
- August 2020
- July 2020
- June 2020
- May 2020
- April 2020
- March 2020
- February 2020
- January 2020
- December 2019
- November 2019
- October 2019
- September 2019
- August 2019
- July 2019
- June 2019
- May 2019
- April 2019
- March 2019
- February 2019
- January 2019
- December 2018
- November 2018
- October 2018
- September 2018
- July 2018
- June 2018
- May 2018
- April 2018
- March 2018
- February 2018
- January 2018
- December 2017
- November 2017
- October 2017
- September 2017
- August 2017
- July 2017
- June 2017
- May 2017
- April 2017
- March 2017
- February 2017
- January 2017
- December 2016
- November 2016
- October 2016
- September 2016
- August 2016
- July 2016
- June 2016
- May 2016
- April 2016
- March 2016
- February 2016
- January 2016
- December 2015
- November 2015
- October 2015
- September 2015
- August 2015
- July 2015
- June 2015
- March 2015
- January 2015
-
Meta
Gunnar Kaasen, a Norwegian musher and his lead dog Balto, who delivered diphtheria antitoxin to Nome, Alaska, saving the city from an epidemic, 1925…
Gunnar Kaasen, a Norwegian musher and his lead dog Balto, who delivered diphtheria antitoxin to Nome, Alaska, saving the city from an epidemic, 1925…
This image is tied to one of the most dramatic public health emergencies in American history, the 1925 serum run to Nome. That winter, diphtheria threatened the isolated Alaskan town, where frozen seas and blizzards made ship travel impossible and aircraft unreliable. Without antitoxin, children in Nome faced near certain death. The only solution was a relay of dog sled teams carrying the serum across roughly 674 miles of subarctic wilderness.
Gunnar Kaasen was one of more than twenty mushers who participated in the relay, but his final leg became the most famous. Battling whiteout conditions, extreme cold, and hurricane force winds, Kaasen relied almost entirely on his lead dog Balto to navigate the final stretch into Nome. Roads vanished beneath drifting snow, visibility collapsed, and a single wrong turn could have been fatal. Despite the conditions, the team arrived in the early hours of February 2, 1925, delivering the serum in time to halt the outbreak.
The run quickly captured international attention and became a symbol of endurance, cooperation, and trust between humans and animals. While later accounts sometimes oversimplified the story, the reality was a collective effort that showcased how fragile life was in remote communities and how ingenuity and grit could overcome geography itself.
The dogsled relay ran nonstop for just over 5 days, more than twice as fast as any previous winter delivery to Nome, and helped prevent what doctors feared could have killed hundreds.

Posted in Uncategorized
Leave a comment
KFF Health News U.S. Solving the Home Care Quandary. Article published in The New York Times
Solving the Home Care Quandary
By Paula Span January 8, 2026

You’re ready to leave the hospital, but you don’t feel able to care for yourself at home yet.
This story also ran on The New York Times. It can be republished for free.
About “The New Old Age”
“The New Old Age” is produced through a partnership with The New York Times .Read More Columns
Or, you’ve completed a couple of weeks in rehab. Can you handle your complicated medication regimen, along with shopping and cooking?
Perhaps you fell in the shower, and now your family wants you to arrange help with bathing and getting dressed.
There are facilities that provide such help, of course, but most older people don’t want to go there. They want to stay at home; that’s the problem.
When older people struggle with daily activities because they have grown frail, because their chronic illnesses have mounted, or because they have lost a spouse or companion, most don’t want to move. For decades, surveys have shown that they prefer to remain in their homes for as long as possible.
That means they need home care, either from family and friends, paid caregivers, or both. But paid home care represents an especially strained sector of the long-term care system, which is experiencing an intensifying labor shortage even as an aging population creates surging demand.
“It’s a crisis,” said Madeline Sterling, a primary care doctor at Weill Cornell Medicine and the director of Cornell University’s Initiative on Home Care Work. “It’s not really working for the people involved,” whether they are patients (who can also be younger people with disabilities), family members, or home care workers.
“This is not about what’s going to happen a decade from now,” said Steven Landers, chief executive of the National Alliance for Care at Home, an industry organization. “Do an Indeed.com search in Anytown, USA, for home care aides, and you’ll see so many listings for aides that your eyes will pop out.”
Email Sign-Up
Subscribe to KFF Health News’ free weekly newsletter, “The Week in Brief.” Your Email Address
Against this grim backdrop, however, some alternatives show promise in upgrading home care jobs and in improving patient care. And they’re growing.
Some background: Researchers and elder care administrators have warned about this approaching calamity for years. Home care is already among the nation’s fastest-growing occupations, with 3.2 million home health aides and personal care aides on the job in 2024, up from 1.4 million a decade earlier, according to PHI, a research and advocacy group.
But the nation will need about 740,000 additional home care workers over the next decade, according to the Bureau of Labor Statistics, and recruiting them won’t be easy. Costs to consumers are high — the median hourly rate for a home health aide in 2024 was $34, the annual Genworth/CareScout survey shows, with big geographic variations. But an aide’s median hourly wage was less than $17.
These remain unstable, low-paying jobs. Of the largely female workforce, about a third of whom are immigrants, 40% live in low-income households and most receive some sort of public assistance.
Even if the agencies that employ them offer health insurance and they work enough hours to qualify, many cannot afford their premium payments.
Unsurprisingly, the turnover rate approaches 80% annually, according to a survey by the ICA Group, a nonprofit organization that promotes co-ops.
But not everywhere. One innovation, still small but expanding: home care cooperatives owned by the workers themselves. The first and largest, Cooperative Home Care Associates in the Bronx borough of New York City, began in 1985 and now employs about 1,600 home care aides. The ICA Group now counts 26 such worker-owned home care businesses nationwide.
“These co-ops are getting exceptional results,” said Geoffrey Gusoff, a family medicine doctor and health services researcher at UCLA. “They have half the turnover of traditional agencies, they hold onto clients twice as long, and they’re paying $2 more an hour” to their owner-employees.
When Gusoff and his co-authors interviewed co-op members for a qualitative study in JAMA Network Open, “we were expecting to hear more about compensation,” he said. “But the biggest single response was, ‘I have more say’” over working conditions, patient care, and the administration of the co-op itself.
“Workers say they feel more respected,” Gusoff said.
Through an initiative to provide financing, business coaching, and technical assistance, the ICA Group intends to boost the national total to 50 co-ops within five years and to 100 by 2040.
Another approach gaining ground: registries that allow home care workers and clients who need care to connect directly, often without involving agencies that provide supervision and background checks but also absorb roughly half the fee consumers pay.
One of the largest registries, Carina, serves workers and clients in Oregon and Washington. Established through agreements with the Service Employees International Union, the nation’s largest health care union, it serves 40,000 providers and 25,000 clients. (About 10% of home care workers are unionized, according to PHI’s analysis.)
Carina functions as a free, “digital hiring hall,” said Nidhi Mirani, its chief executive. Except in the Seattle area, it serves only clients who receive care through Medicaid, the largest funder of care at home. State agencies handle the paperwork and oversee background checks.
Hourly rates paid to independent providers found on Carina, which are set by union contracts, are usually lower than what agencies charge, while workers’ wages start at $20, and they receive health insurance, paid time off, and, in some cases, retirement benefits.
Other registries may be operated by states, as in Massachusetts and Wisconsin, or by platforms like Direct Care Careers, available in four states. “People are seeking a fit in who’s coming into their homes,” Mirani said. “And individual providers can choose their clients. It’s a two-way street.”
Finally, recent studies indicate ways that additional training for home care workers can pay off.
“These patients have complex conditions,” Sterling said of the aides. Home care workers, who take blood pressure readings, prepare meals, and help clients stay mobile, can spot troubling symptoms as they emerge.
Her team’s recent clinical trial of home health aides caring for patients with heart failure — “the No. 1 cause of hospitalization among Medicare beneficiaries,” Sterling pointed out — measured the effects of a 90-minute virtual training module about its symptoms and management.
“Leg swelling. Shortness of breath. They’re the first signs that the disease is not being controlled,” Sterling said.
In the study, involving 102 aides working for VNS Health, a large nonprofit agency in New York, the training was shown to enhance their knowledge and confidence in caring for clients with heart failure.
Moreover, when aides were given a mobile health app that allowed them to message their supervisors, they made fewer 911 calls and their patients made fewer emergency room visits.
Small-scale efforts like registries, co-ops, and training programs do not directly address home care’s most central problem: cost.
Medicaid underwrites home care for low-income older adults who have few assets, though the Trump administration’s new budget will slash Medicaid by more than $900 billion over the next decade. The well-off theoretically can pay out-of-pocket.
But “middle-class retired families either spend all their resources and essentially bankrupt themselves to become eligible for Medicaid, or they go without,” Landers said. Options like assisted living and nursing homes are even more expensive.
The United States has never committed to paying for long-term care for the middle class, and it seems unlikely to do so under this administration. Still, savings from innovations like these can reduce costs and might help expand home care through federal or state programs. Several tests and pilots are underway.
Home care workers “have a lot of insight into patients’ conditions,” Sterling said. “Training them and giving them technological tools shows that if we’re trying to keep patients at home, here’s a way to do that with the workforce that’s already there.”
The New Old Age is produced through a partnership with The New York Times.
La Pieta … Michelangelo
Imagine starting with a block of stone and ending up with this. When Michelangelo was 23 years old, he was commissioned by a cardinal to produce “the most beautiful work of marble in Rome, one that no living artist could better.” It was to capture the moment the Virgin Mary held Christ in her arms after he was taken down from the cross.
Accepting the challenge, the relatively unknown young man got to work on a block of Carrara marble. Less than 2 years later, the work was installed at the cardinal’s grave, on the very same day he died. When revealed, it was met with sheer disbelief. Most doubted it was the young man’s work, so he carved into the sash across Mary’s chest: “Michelangelo Buonarroti of Florence made this.”
La Pietà embodies the power of beauty as a transcendent force. It takes the worst possible human tragedy — the loss of a grieving parent — and transforms it into something that helps you to instead see the ecstatic joy of human life.
Michelangelo saw in the dead body of Christ such compassionate suffering that it drove him to create the most beautiful thing ever hewn from a block of marble. Vasari called it a “miracle that a formless block of stone could ever have been reduced to a perfection that nature is scarcely able to create in the flesh.”
La Pietà now lives at St. Peter’s Basilica, where it has been for over 500 years.

Posted in Uncategorized
Leave a comment
UK Home Secretary: It was her “DREAM FOR THE EYES OF THE STATE TO BE ON YOU AT ALL TIMES” … Add what AI and Face Recognition will do
Posted in Uncategorized
Leave a comment
Elon Musk’s Full Speech Friday At Davos (Note: silences removed and boosted audio!)
Posted in Uncategorized
Leave a comment
Futurism: Majority of CEOs Alarmed as AI Delivers No Financial Returns
Dude, Where’s My Return?
Majority of CEOs Alarmed as AI Delivers No Financial Returns
They’re worried they’re not spending enough on AI.
Published Jan 21, 2026 12:08 PM EST

Investors continue to fret over an AI bubble “reckoning,” as gains in productivity from the tech remain elusive.
According to a recent survey by professional services network PwC, more than half of the 4,454 CEO respondents said “their companies aren’t yet seeing a financial return from investments in AI.”
Only 30 percent reported increased revenue from AI in the last 12 months. However, a far more significant 56 percent said AI has failed to either boost revenue or lower costs. A mere 12 percent of CEOs reported that it’d accomplished both goals.
The findings once again underline lingering questions about the effectiveness of the tech. That’s despite AI companies pouring tens of billions into data center buildouts and related infrastructure.
Instead of looking for other avenues for growth, though, PwC found that executives are worried about falling behind by not leaning into AI enough.
“A small group of companies are already turning AI into measurable financial returns, whilst many others are still struggling to move beyond pilots,” said PwC global chairman Mohamed Kande in a statement. “That gap is starting to show up in confidence and competitiveness, and it will widen quickly for those that don’t act.”
PwC also pointed out that most companies were lacking the “AI foundations, such as clearly defined road maps and sufficient levels of investment” to realize a return.
But whether pouring even more money into AI will suddenly turn the tech into a money maker — and not a major expense on the balance sheet — remains the subject of a heated debate.
For now, the prognosis is still looking somewhat grim. Last year, a frequently-cited MIT report found that a staggering 95 percent of attempts to incorporate generative AI into business so far are failing to lead to “rapid revenue acceleration.”
The effectiveness of the tech itself has also repeatedly been called into question, from frequent hallucinations and an inability to complete real-world office tasks to ongoing concerns over data security.
The topic of tangible returns on investment from AI is bound to be a major focus this year as executives wonder how to translate all that hype into real-world implementations — and whether it’ll actually help their bottom lines in the long run.
More on the AI hype: Terrified Investors Are Bracing for an AI Bubble “Reckoning”
Victor Tangermann
Senior Editor
I’m a senior editor at Futurism, where I edit and write about NASA and the private space sector, as well as topics ranging from SETI and artificial intelligence to tech and medical policy.
Posted in Uncategorized
Tagged ai, artificial-intelligence, chatgpt, finance, technology
Leave a comment